DSP MF and FII sell 1.36 lakh Alembic Pharma shares; holding falls to 2.97%

Fii Holding DeclinedOwnership Changes View source PDF Explain this filing

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.3%Reaction day

₹854.00

prior close

₹846.80

announcement price

In-mkt

timing

Nifty Microcap 250market+1.0%+0.2% vs market

Pharmaceuticals peers, median of 173sector+0.4%+0.9% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.1

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.3+1.0+0.2+0.4+0.9

Next day

-3.4+0.8-4.2-0.3-3.1

-4.1-0.5-3.6-1.3-2.8

-2.6-0.5-2.0-1.6-1.0

-1.8+0.8-2.6-1.0-0.8

-2.5+0.5-3.1-1.1-1.5

-6.2-2.0-4.2-3.2-3.0

15d

-8.9-6.4-2.5-7.2-1.7

-6.7-5.9-0.8-5.1-1.6

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

DSP Trustee, on behalf of DSP MF schemes and foreign fund DSP Global Funds ICAV, sold 1,36,574 shares (0.07%) of Alembic Pharma in the open market on September 24, 2026. Combined holding fell from 3.04 percent (59.68 lakh shares) to 2.97 percent (58.32 lakh shares). The decline crosses the 2 percent disclosure trigger from their last filing in November 2023. Acquirers are not promoters.

Likely market impact

Institutional selling by mutual fund and foreign fund, not promoter action; limited effect on promoter holdings or stock price direction.